Detrusor underactivity in symptomatic anterior pelvic organ prolapse.

anterior vaginal wall defect detrusor underactivity pelvic organ prolapse urodynamics

Journal

Central European journal of urology
ISSN: 2080-4806
Titre abrégé: Cent European J Urol
Pays: Poland
ID NLM: 101587101

Informations de publication

Date de publication:
2024
Historique:
received: 22 10 2023
revised: 20 12 2023
accepted: 28 12 2023
medline: 22 4 2024
pubmed: 22 4 2024
entrez: 22 4 2024
Statut: ppublish

Résumé

The aim of this study was to assess the detrusor underactivity (DUA) prevalence of females with symptomatic anterior pelvic organ prolapse (POP) and to evaluate the relationship between DUA and POP stage. This was a prospective study recruiting women with symptomatic anterior POP. Patients with symptomatic stage 2-4 POP quantification system (POP-Q) who underwent urodynamics (UD) between January 2018 and April 2021 were included. Data on 330 women (mean age 63.7 ±18.4 years old) with anterior vaginal wall defect were enrolled. Concomitant apical defect (uterine/vaginal vault) requiring surgical correction was diagnosed in 38 women (11.5%). DUA was found in 166 females (50.3%). In DUA women, POP-Q stage 2 was found in 45.2%, stage 3 in 50.9% and stage 4 in 76.5%. Only stage POP-Q stage 4 showed a statistically significant difference between DUA and non-DUA females (p 0.006). In women with symptomatic POP, regardless of the POP-Q stage, the chance of DUA occurrence was high. DUA was diagnosed in approximately half of the women undergoing UD for symptomatic POP, and it was three-fold higher in cases of POP-Q stage 4. Due to the high incidence of DUA in POP-Q 4 stage, it may be advantageous to identify and treat prolapse before they progress to stage 4.

Identifiants

pubmed: 38645803
doi: 10.5173/ceju.2023.246
pii: 246
pmc: PMC11032042
doi:

Types de publication

Journal Article

Langues

eng

Pagination

77-81

Informations de copyright

Copyright by Polish Urological Association.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Emanuele Rubilotta (E)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona University, Verona, Italy.

Marilena Gubbiotti (M)

Department of Urology, San Donato Hospital, Arezzo, Italy.

Achim Herms (A)

Ärztlicher Leiter Neurourologische Ambulanz, Landeskrankenhaus Universitätskliniken, Innsbruck, Austria.

Howard Goldman (H)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, United States of America.

Alessandro Antonelli (A)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona University, Verona, Italy.

Matteo Balzarro (M)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona University, Verona, Italy.

Classifications MeSH